The European Commission said that no final decision had been made about the possible termination of a contract with Valneva SE (NASDAQ: VALN) to supply its COVID-19 vaccine to the European Union.
Companies Reporting Before The Bell
• Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
Strong immunogenicity profile observed in study participants aged 5-17 years one month after the primary vaccination series
Safety profile observed in pediatric participants similar to previously reported data in
Britain’s medicines regulator approved the use of Moderna Inc’s (NASDAQ:MRNA) COVID-19 vaccine in children between six and 11 years. The Medicines and…